Emergent BioSolutions’ $150 Million At-the-market Offering

Davis Polk advised the sales agents, RBC Capital Markets, LLC and Evercore Group L.L.C., on the transaction. Emergent BioSolutions Inc., an American multinational specialty biopharmaceutical company headquartered in…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now